Zenlabs Ethica Ltd

As of June 30, 2026, Zenlabs Ethica Ltd carries a market capitalization of 211.60M, placing it among publicly traded companies globally. Its enterprise value stands at 211.60M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Zenlabs Ethica Ltd has 6.49M shares outstanding.

These figures are as of June 30, 2026.

These figures are as of June 30, 2026. The EV/Sales ratio of 0.43 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 211.60M versus a market cap of 211.60M, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

Over the twelve months ended June 30, 2026, Zenlabs Ethica Ltd recorded 1.27M in income tax expense. The company reported a pretax loss of -24.13M and -25.40M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 23, 2026, Zenlabs Ethica Ltd's stock has declined approximately 14.01% over the past 52 weeks. The 50-day moving average sits at 28.05, while the 200-day moving average is 26.18.

Over the twelve months ended June 30, 2026, Zenlabs Ethica Ltd generated 496.22M in revenue and converted that into -25.40M in net income, yielding earnings per share of -3.94. EBITDA reached -11.26M, while operating income came in at 2.44M.

Over the twelve months ended June 30, 2026, Zenlabs Ethica Ltd posted a gross margin of 20.92, reflecting its pricing power and cost economics. The operating margin of 0.49 and net profit margin of -5.12 provide insight into operational efficiency.

Zenlabs Ethica Ltd's most recent stock split took place on October 11, 2018 with a 20:21 split ratio.